معرفی
Roslyn Tedja is an Assistant Professor in the Department of Obstetrics and Gynecology. Her research focuses on molecular mechanisms driving ovarian cancer progression, particularly epithelial-mesenchymal transition (EMT), intra-tumoral heterogeneity, and nanoparticle-based therapeutic strategies.
- Education: Ph.D. in Chemical Engineering, University of New South Wales, Sydney, Australia
Research Interests
Tedja's work spans:
- Molecular regulation of EMT in ovarian cancer
- Intra-tumoral heterogeneity in disease relapse
- Nanoparticle platform design for chemotherapy delivery
- Adipose microenvironment-cancer cell interactions
- Exosomal miRNA-mediated metastasis
Recent Publications
Her 2023–2024 studies highlight:
- Adipose microenvironment's role in hypersialylation (Front Oncol)
- MNRR1's impact on tumor progression (Transl Oncol)
- Exosomal miR-421 targeting CBX7 (J Ovarian Res)
- EMT hybrid cell generation (Cancers)
Earlier work (2011–2012) addressed nanoparticle-cell interactions in non-cancerous contexts.
۰مقاله منتشرشده
